EpiCast Report: Schizophrenia - Epidemiology Forecast to 2022 - WTOC-TV: Savannah, Beaufort, SC, News, Weather & Sports

EpiCast Report: Schizophrenia - Epidemiology Forecast to 2022

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE ReportBuyer

LONDON, Feb. 19, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

EpiCast Report: Schizophrenia - Epidemiology Forecast to 2022

EpiCast Report: Schizophrenia - Epidemiology Forecast to 2022

Summary

Schizophrenia is a chronic, severe, and disabling group of psychotic disorders characterized by fundamental disturbances of thinking such as hallucinations, delusions, disorganized communication, and reduced motivation. Schizophrenia affects men and women equally, and usually starts in young adulthood (between ages 16 and 30 years). Due to the chronic nature of the condition, schizophrenia requires lifelong treatment. Although treatment helps in relieving symptoms of schizophrenia to some extent, most people with the disorder have to cope with the symptoms throughout their lives.

Schizophrenia causes enormous burden on the patients and their families, as well as on society in the form of treatment expenses, loss of productivity, and disability. Because the onset of schizophrenia is usually in young adulthood, which is the most critical period of educational, occupational, and social development, the consequences often lead to lifelong disability with deterioration in functional capacity. Patients with schizophrenia also have increased physical morbidity and mortality compared with the population without a psychotic disorder.

GlobalData's epidemiological forecast for diagnosed prevalent cases of schizophrenia in the 7MM is supported by age- and sex-specific diagnosed prevalence of schizophrenia obtained from country-specific, population-based studies that are nationally representative of the entire population in the respective markets. Moreover, GlobalData epidemiologists selected studies that used uniform diagnostic criteria across markets defined by the World Health Organization's International Classification of Diseases 9th revision (ICD-9).

Scope

- The Schizophrenia EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of schizophrenia in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). In addition, the report also includes a 10-year epidemiological forecast of the diagnosed prevalent cases of schizophrenia segmented by age and sex.
- The schizophrenia epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global schizophrenia market.
- Quantify patient populations in the global schizophrenia market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for schizophrenia therapeutics in each of the markets covered.

Table of Contents

1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors and Comorbidities 9
3.2.1 Psychiatric illness in first-degree relatives is a strong predictor of schizophrenia 10
3.2.2 Advancing paternal age increases the risk of schizophrenia in offspring 11
3.2.3 Psychiatric comorbidities are common in patients with schizophrenia 12
3.2.4 People with schizophrenia suffer from several medical comorbidities 13
3.3 Global Trends 16
3.3.1 US 18
3.3.2 5EU 19
3.3.3 Japan 22
3.4 Forecast Methodology 23
3.4.1 Sources Used 24
3.4.2 Sources Not Used 26
3.4.3 Forecast Assumptions and Methods, Prevalent Cases 27
3.5 Epidemiological Forecast of Schizophrenia (2012-2022) 29
3.5.1 Diagnosed Prevalent Cases of Schizophrenia 29
3.5.2 Age-Specific Prevalent Cases of Schizophrenia 31
3.5.3 Sex-Specific Prevalent Cases of Schizophrenia 33
3.5.4 Age-Standardized Diagnosed Prevalence of Schizophrenia 35
3.6 Discussion 37
3.6.1 Epidemiological Forecast Insight 37
3.6.2 Limitations of the Analysis 37
3.6.3 Strengths of the Analysis 38
4 Appendix 39
4.1 Bibliography 39
4.2 About the Authors 42
4.2.1 Epidemiologists 42
4.2.2 Reviewers 42
4.2.3 Global Director of Epidemiology and Health Policy 43
4.2.4 Global Head of Healthcare 44
4.3 About GlobalData 45
4.4 About EpiCast 45
4.5 Disclaimer 46

List of Tables

Table 1: ICD-9 Codes and Classification of Schizophrenia 9
Table 2: Risk Factors and Comorbidities for Schizophrenia 10
Table 3: Prevalence of Most Frequent Comorbidities in People with Schizophrenia and People without Schizophrenia, Both Sexes, Ages ?18 Years, 2007 14
Table 4: Prevalence of Most Frequent Comorbidities in People with Schizophrenia and People without Schizophrenia, 1996-2001 15
Table 5: Distribution of Estimates of Schizophrenia from Three Meta-Analysis Studies of Incidence, Prevalence, and Mortality, by Sex 17
Table 6: Trends in the Annual Incidence of Schizophrenia (per 100,000 Population), Portogruaro, Italy, 1982-1989 19
Table 7: Trends in the Prevalence of Schizophrenia (per 1,000 Population), Portogruaro, Italy, 1982-1989 20
Table 8: Trends in the Prevalence of Schizophrenia (per 1,000 Population), Japan, 1984-2008 23
Table 9: Sources of Schizophrenia Prevalence Data 24
Table 10: 7MM, Diagnosed Prevalent Cases of Schizophrenia, Both Sexes, Ages ?15 Years, N, 2012-2022 30
Table 11: 7MM, Age-Specific Diagnosed Prevalent Cases of Schizophrenia, Both Sexes, N (Row %), 2012 32
Table 12: 7MM, Sex-Specific Diagnosed Prevalent Cases of Schizophrenia, Ages ?15 Years, N (Row %), 2012 34

List of Figures

Figure 1: 7MM, Diagnosed Prevalent Cases of Schizophrenia, Both Sexes, Ages ?15 Years, N, 2012-2022 30
Figure 2: 7MM, Age-Specific Diagnosed Prevalent Cases of Schizophrenia, Both Sexes, N, 2012 33
Figure 3: 7MM, Sex-Specific Diagnosed Prevalent Cases of Schizophrenia, Ages ?15 Years, N, 2012 35
Figure 4: 6MM, Age-Standardized Diagnosed Prevalence (%) of Schizophrenia, Ages ?15 Years, by Sex, 2012 36

Read the full report:
EpiCast Report: Schizophrenia - Epidemiology Forecast to 2022
http://www.reportbuyer.com/pharma_healthcare/diseases/epicast_report_schizophrenia_epidemiology_forecast_2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow